tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RDY Stock Latest News

Coya Therapeutics to sell 2.522M shares at $4.40 in private placement
The FlyCoya Therapeutics to sell 2.522M shares at $4.40 in private placement
2d ago
RDY
COYA
Dr. Reddy’s Q3 Earnings Call: Growth Amid Margin Strain
PremiumCompany Announcements
Dr. Reddy’s Q3 Earnings Call: Growth Amid Margin Strain
6d ago
RDY
Dr. Reddy’s Russian Subsidiary Faces VAT Reclassification Penalty Deemed Immaterial
PremiumCompany Announcements
Dr. Reddy’s Russian Subsidiary Faces VAT Reclassification Penalty Deemed Immaterial
6d ago
6K
RDY
Is RDY a Buy, Before Earnings?
PremiumPre-Earnings
Is RDY a Buy, Before Earnings?
13d ago
RDY
Dr. Reddy’s Launches First-to-Market Generic of Extra-Strength Pataday in U.S. OTC Eye-Care Segment
PremiumCompany Announcements
Dr. Reddy’s Launches First-to-Market Generic of Extra-Strength Pataday in U.S. OTC Eye-Care Segment
17d ago
6K
RDY
Dr. Reddy’s Receives USFDA Post-Application Action Letter for Bachupally Biologics Facility
PremiumCompany AnnouncementsDr. Reddy’s Receives USFDA Post-Application Action Letter for Bachupally Biologics Facility
20d ago
6K
RDY
Dr. Reddy’s to Announce Q3 FY26 Results and Host Earnings Call on January 21, 2026
Premium
Company Announcements
Dr. Reddy’s to Announce Q3 FY26 Results and Host Earnings Call on January 21, 2026
23d ago
6K
RDY
Dr. Reddy’s Faces GST Penalty Orders for FY 2018–23, Sees No Material Financial Impact
Premium
Company Announcements
Dr. Reddy’s Faces GST Penalty Orders for FY 2018–23, Sees No Material Financial Impact
1M ago
6K
RDY
Dr. Reddy’s Faces FDA Setback on AVT03 Denosumab Biosimilar After Manufacturing Inspection
PremiumCompany Announcements
Dr. Reddy’s Faces FDA Setback on AVT03 Denosumab Biosimilar After Manufacturing Inspection
1M ago
6K
RDY
Dr. Reddy’s Schedules January 21 Board Meeting to Review Q3 FY26 Results, Closes Trading Window
PremiumCompany Announcements
Dr. Reddy’s Schedules January 21 Board Meeting to Review Q3 FY26 Results, Closes Trading Window
1M ago
6K
RDY
Dr. Reddy’s Laboratories to Engage with Investors at Chennai Conference
PremiumCompany Announcements
Dr. Reddy’s Laboratories to Engage with Investors at Chennai Conference
2M ago
6K
RDY
Dr. Reddy’s Laboratories Receives USFDA Observations Post-Inspection
PremiumCompany Announcements
Dr. Reddy’s Laboratories Receives USFDA Observations Post-Inspection
2M ago
6K
RDY
Dr. Reddy’s Laboratories Allots Equity Shares Under ESOPs
PremiumCompany AnnouncementsDr. Reddy’s Laboratories Allots Equity Shares Under ESOPs
2M ago
6K
RDY
Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
Premium
The Fly
Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
2M ago
V
GM
Dr. Reddy’s and Immutep Forge Strategic Partnership for Eftilagimod Alfa
Premium
Company Announcements
Dr. Reddy’s and Immutep Forge Strategic Partnership for Eftilagimod Alfa
2M ago
6K
RDY
Immutep, Dr Reddy’s enters strategic collaboration for Eftilagimod Alfa
PremiumThe Fly
Immutep, Dr Reddy’s enters strategic collaboration for Eftilagimod Alfa
2M ago
RDY
IMMP
Dr. Reddy’s Laboratories to Engage with Investors at Singapore Conference
PremiumCompany Announcements
Dr. Reddy’s Laboratories to Engage with Investors at Singapore Conference
2M ago
6K
RDY
Dr. Reddy’s Laboratories to Engage with Investors at Tokyo Conference
PremiumCompany Announcements
Dr. Reddy’s Laboratories to Engage with Investors at Tokyo Conference
2M ago
6K
RDY
Dr. Reddy’s Gains EU Approval for Denosumab Biosimilar
PremiumCompany Announcements
Dr. Reddy’s Gains EU Approval for Denosumab Biosimilar
2M ago
6K
RDY
Dr. Reddy’s Laboratories Schedules Investor Conferences for November 2025
PremiumCompany AnnouncementsDr. Reddy’s Laboratories Schedules Investor Conferences for November 2025
2M ago
6K
RDY
Dr. Reddy’s Laboratories to Engage with Investors at Mumbai Conference
Premium
Company Announcements
Dr. Reddy’s Laboratories to Engage with Investors at Mumbai Conference
3M ago
6K
RDY
Dr. Reddy’s API Facility Passes USFDA Inspection with Zero Observations
Premium
Company Announcements
Dr. Reddy’s API Facility Passes USFDA Inspection with Zero Observations
3M ago
6K
RDY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >